FR2386523A1 - Derives du prostane et medicaments qui en contiennent - Google Patents

Derives du prostane et medicaments qui en contiennent

Info

Publication number
FR2386523A1
FR2386523A1 FR7810063A FR7810063A FR2386523A1 FR 2386523 A1 FR2386523 A1 FR 2386523A1 FR 7810063 A FR7810063 A FR 7810063A FR 7810063 A FR7810063 A FR 7810063A FR 2386523 A1 FR2386523 A1 FR 2386523A1
Authority
FR
France
Prior art keywords
products containing
medicinal products
prostane derivatives
prostane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7810063A
Other languages
English (en)
French (fr)
Other versions
FR2386523B1 (it
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2386523A1 publication Critical patent/FR2386523A1/fr
Application granted granted Critical
Publication of FR2386523B1 publication Critical patent/FR2386523B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7810063A 1977-04-05 1978-04-05 Derives du prostane et medicaments qui en contiennent Granted FR2386523A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772715838 DE2715838A1 (de) 1977-04-05 1977-04-05 Neue prostanderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2386523A1 true FR2386523A1 (fr) 1978-11-03
FR2386523B1 FR2386523B1 (it) 1981-02-13

Family

ID=6005974

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7810063A Granted FR2386523A1 (fr) 1977-04-05 1978-04-05 Derives du prostane et medicaments qui en contiennent

Country Status (11)

Country Link
JP (1) JPS53124238A (it)
BE (1) BE865705A (it)
CH (1) CH638773A5 (it)
DE (1) DE2715838A1 (it)
DK (1) DK150778A (it)
FR (1) FR2386523A1 (it)
GB (1) GB1601994A (it)
IE (1) IE46864B1 (it)
IT (1) IT1093506B (it)
LU (1) LU79369A1 (it)
NL (1) NL7803415A (it)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405943A1 (fr) * 1976-11-29 1979-05-11 Merck Patent Gmbh Nouveaux derives de l'acide 13-prostenoique, leur preparation et leur application en tant que medicaments
WO1994006433A1 (en) * 1992-09-21 1994-03-31 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO1994008587A1 (en) * 1992-10-21 1994-04-28 Allergan, Inc. Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6403649B1 (en) 1992-09-21 2002-06-11 Allergan Sales, Inc. Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US8278353B2 (en) 2005-03-16 2012-10-02 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US9801891B2 (en) 2009-12-22 2017-10-31 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066518A1 (fr) * 2000-03-09 2001-09-13 Ono Pharmaceutical Co., Ltd. E-ALCOOLS PHENYL-PROSTAGLANDINE φ-SUBSTITUES, PROCEDE DE PREPARATION ASSOCIE ET MEDICAMENTS RENFERMANT CES DERNIERS EN TANT QUE PRINCIPE ACTIF
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7101906B2 (en) * 2004-11-16 2006-09-05 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
US7183324B2 (en) 2004-11-23 2007-02-27 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
ES2452026T3 (es) 2005-11-03 2014-03-31 Allergan, Inc. Prostaglandinas y análogos como agentes para disminuir la presión intraocular

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258845A1 (it) * 1974-01-26 1975-08-22 May & Baker Ltd

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258845A1 (it) * 1974-01-26 1975-08-22 May & Baker Ltd

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405943A1 (fr) * 1976-11-29 1979-05-11 Merck Patent Gmbh Nouveaux derives de l'acide 13-prostenoique, leur preparation et leur application en tant que medicaments
WO1994006433A1 (en) * 1992-09-21 1994-03-31 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6403649B1 (en) 1992-09-21 2002-06-11 Allergan Sales, Inc. Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO1994008587A1 (en) * 1992-10-21 1994-04-28 Allergan, Inc. Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5385945A (en) * 1992-10-21 1995-01-31 Allergan, Inc. 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5552434A (en) * 1992-10-21 1996-09-03 Allergan 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds
US5674910A (en) * 1992-10-21 1997-10-07 Allergan 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5773654A (en) * 1992-10-21 1998-06-30 Allergan 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds
US8278353B2 (en) 2005-03-16 2012-10-02 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8299118B2 (en) 2005-03-16 2012-10-30 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8309605B2 (en) 2005-03-16 2012-11-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8338479B2 (en) 2005-03-16 2012-12-25 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US8586630B2 (en) 2005-03-16 2013-11-19 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8772338B2 (en) 2005-03-16 2014-07-08 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933120B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933127B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9155716B2 (en) 2005-03-16 2015-10-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9801891B2 (en) 2009-12-22 2017-10-31 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Also Published As

Publication number Publication date
IE780671L (en) 1978-10-05
GB1601994A (en) 1981-11-04
IT1093506B (it) 1985-07-19
NL7803415A (nl) 1978-10-09
BE865705A (fr) 1978-10-05
IT7821951A0 (it) 1978-04-04
FR2386523B1 (it) 1981-02-13
DE2715838A1 (de) 1978-10-19
LU79369A1 (de) 1978-07-13
IE46864B1 (en) 1983-10-19
CH638773A5 (en) 1983-10-14
DK150778A (da) 1978-10-06
JPS53124238A (en) 1978-10-30

Similar Documents

Publication Publication Date Title
FR2398741A1 (fr) Derives de la prostaglandine i2 et medicaments qui en contiennent
FR2387220A1 (fr) Derives du benzimidazole et medicaments qui en contiennent
FR2370755A1 (fr) Spirolactones steroidiques et medicaments qui en contiennent
FR2415616A1 (fr) Derives d'acides phenylacetiques et medicaments qui en contiennent
FR2433512A1 (fr) Derives de l'indane et medicaments qui en contiennent
FR2370731A1 (fr) Nouveaux derives de la piperidine polysubstitues, leurs procedes de preparation et leur application pharmaceutique
FR2386523A1 (fr) Derives du prostane et medicaments qui en contiennent
FR2414504A1 (fr) Oxadiazoles-1,2,4 et produits herbicides qui en contiennent
FR2312240A1 (fr) Derives du prostane et medicaments qui en contiennent
FR2398053A1 (fr) Bis-carbamates et produits herbicides qui en contiennent
FR2395993A1 (fr) Derives du prostane a triple liaison en 18 et medicaments qui en contiennent
FR2378772A1 (fr) Thiazolyl-cinnamonitriles et produits pesticides qui en contiennent
FR2366312A1 (fr) Corticosteroides et medicaments qui en contiennent
FR2370082A1 (fr) Pigments mono-azoiques et leur preparation
FR2355021A1 (fr) Nouveaux derives d'imidazothiazine et leur application en tant que medicaments
FR2378026A1 (fr) Medicaments contenant des derives de sulfure d'hydroxymethyl-2 amino-2' diphenyle
FR2426674A1 (fr) Derives de cyclohexene-1,2-dicarboxamides et compositions herbicides les contenant
FR2361361A1 (fr) Nouveaux derives du cyclopentane et medicaments contenant ces substances
FR2393031A1 (fr) Pigments monoazoiques et leur preparation
FR2356636A1 (fr) Derives d'acides prostanoiques et medicaments qui en contiennent
FR2366313A1 (fr) Derives de la chloro-9 prednisolone et medicaments qui en contiennent
FR2355830A1 (fr) Nouveaux derives de 6-7-benzomorphane, leur obtention et composition pharmaceutique les contenant
FR2415107A1 (fr) Derives de 5-phenethyl-2-oxazolidone, leur procede de preparation et leur application en therapeutique
FR2428649A1 (fr) Diesters en 17,21 de l'hydrocortisone et medicaments qui en contiennent
FR2373561A1 (fr) Corticosteroides et medicaments qui en contiennent

Legal Events

Date Code Title Description
ST Notification of lapse